Literature DB >> 19246254

Optimized method for the determination of itopride in human plasma by high-performance liquid chromatography with fluorimetric detection.

Pavel Ptácek1, Josef Klíma, Jan Macek.   

Abstract

A high-performance liquid chromatographic method with fluorescence detection for the determination of itopride in human plasma is reported. The sample preparation was based on liquid-liquid extraction of itopride from plasma with t-butylmethylether and dichloromethane (70:30, v/v) mixture followed by a back extraction of the analyte to the phosphate buffer (pH 3.2). Liquid chromatography was performed on an octadecylsilica column (55 mm x 4 mm, 3 microm particles), the mobile phase consisted of acetonitrile-triethylamine-15 mM dihydrogenpotassium phosphate (14.5:0.5:85, v/v/v), pH of the mobile phase was adjusted to 4.8. The run time was 3 min. The fluorimetric detector was operated at 250/342 nm (excitation/emission wavelength). Naratriptan was used as the internal standard. The limit of quantitation was 9.5 ng/ml using 0.5 ml of plasma. The method precision and inaccuracy were less than 8%. The assay was applied to the analysis of samples from a bioequivalence study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246254     DOI: 10.1016/j.jchromb.2009.02.023

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Stability-indicating spectrofluorimetric method for determination of itopride hydrochloride in raw material and pharmaceutical formulations.

Authors:  Mohamed I Walash; Fawzia Ibrahim; Manal I Eid; Samah Abo El Abass
Journal:  J Fluoresc       Date:  2013-07-14       Impact factor: 2.217

2.  Analytical method development and validation of simultaneous estimation of rabeprazole, pantoprazole, and itopride by reverse-phase high-performance liquid chromatography.

Authors:  Senthamil Selvan Perumal; Sanmuga Priya Ekambaram; Samundeswari Raja
Journal:  J Food Drug Anal       Date:  2014-10-28       Impact factor: 6.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.